{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:25:27Z","timestamp":1791617127138,"version":"4.3.4"},"reference-count":174,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Solid organ transplantation is a life-saving treatment for people with end-stage organ disease. Immune-mediated transplant rejection is a common complication that decreases allograft survival. Although immunosuppression is required to prevent rejection, it also increases the risk of infection. Some infections, such as cytomegalovirus and BK virus, can promote inflammatory gene expression that can further tip the balance toward rejection. BK virus and other infections can induce damage that resembles the clinical pathology of rejection, and this complicates accurate diagnosis. Moreover, T cells specific for viral infection can lead to rejection through heterologous immunity to donor antigen directly mediated by antiviral cells. Thus, viral infections and allograft rejection interact in multiple ways that are important to maintain immunologic homeostasis in solid organ transplant recipients. Better insight into this dynamic interplay will help promote long-term transplant survival.<\/jats:p>","DOI":"10.1097\/tp.0000000000004297","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T12:02:35Z","timestamp":1661515355000},"page":"584-595","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":51,"title":["Infection, Rejection, and the Connection"],"prefix":"10.1097","volume":"107","author":[{"given":"Lauren E.","family":"Higdon","sequence":"first","affiliation":[{"name":"Department of Medicine\/Nephrology, Stanford University, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Nephrology, Stanford University, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Maltzman","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Nephrology, Stanford University, Palo Alto, CA."},{"name":"Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"Suppl 2","key":"R1-20250604","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ajt.16492","article-title":"OPTN\/SRTR 2019 annual data report: heart.","volume":"21","author":"Colvin","year":"2021","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R2-20250604","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 annual data report: kidney.","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R3-20250604","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 annual data report: liver.","volume":"21","author":"Kwong","year":"2021","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R4-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ajt.16495","article-title":"OPTN\/SRTR 2019 annual data report: lung.","volume":"21","author":"Valapour","year":"2021","journal-title":"Am J Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1600-6143.2010.03053.x","article-title":"T cell-mediated rejection of kidney transplants: a personal viewpoint.","volume":"10","author":"Halloran","year":"2010","journal-title":"Am J Transplant"},{"key":"R6-20250604","first-page":"46","article-title":"Antibody-mediated rejection: a review.","volume":"17","author":"Garces","year":"2017","journal-title":"Ochsner J"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00467-008-0869-z","article-title":"Chronic allograft nephropathy.","volume":"24","author":"Fletcher","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1183\/09031936.05.00057404","article-title":"Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?","volume":"25","author":"Verleden","year":"2005","journal-title":"Eur Respir J"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3748\/wjg.v10.i13.1857","article-title":"Cytomegalovirus and chronic allograft rejection in liver transplantation.","volume":"10","author":"Gao","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/TP.0000000000001215","article-title":"Chronic lung allograft dysfunction: a systematic review of mechanisms.","volume":"100","author":"Royer","year":"2016","journal-title":"Transplantation"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2215\/CJN.15590920","article-title":"Chronic allograft injury.","volume":"16","author":"Langewisch","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1749-8090-8-48","article-title":"Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy.","volume":"8","author":"Kaczorowski","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"613641","DOI":"10.1155\/2014\/613641","article-title":"Hyperacute rejection of a living unrelated kidney graft.","volume":"2014","author":"Tittelbach-Helmrich","year":"2014","journal-title":"Case Rep Med"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00007890-199304000-00013","article-title":"Risk factors for chronic rejection in renal allograft recipients.","volume":"55","author":"Almond","year":"1993","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2321-3868.121646","article-title":"Chronic allograft rejection: a significant hurdle to transplant success.","volume":"2","author":"Kloc","year":"2014","journal-title":"Burns Trauma"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"651222","DOI":"10.3389\/fphar.2021.651222","article-title":"Therapies for chronic allograft rejection.","volume":"12","author":"Kim","year":"2021","journal-title":"Front Pharmacol"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3389\/fimmu.2018.02548","article-title":"T cell allorecognition pathways in solid organ transplantation.","volume":"9","author":"Siu","year":"2018","journal-title":"Front Immunol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T lymphocytes and allograft rejection.","volume":"7","author":"Marino","year":"2016","journal-title":"Front Immunol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2215\/CJN.11991019","article-title":"Evaluation and treatment of acute rejection in kidney allografts.","volume":"15","author":"Cooper","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1432-2277.2000.tb01019.x","article-title":"Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.","volume":"13","author":"Toupance","year":"2000","journal-title":"Transpl Int"},{"issue":"Suppl 1","key":"R22-20250604","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.2215\/CJN.00920207","article-title":"BK virus nephropathy and kidney transplantation.","volume":"2","author":"Bohl","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/gft036","article-title":"What do we know about adenovirus in renal transplantation?","volume":"28","author":"Florescu","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/ndt\/gfg251","article-title":"Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.","volume":"18","author":"Anglicheau","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/intimm\/2.1.9","article-title":"Are primary alloresponses truly primary?","volume":"2","author":"Lombardi","year":"1990","journal-title":"Int Immunol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus.","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients.","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cmi.2014.75","article-title":"The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?","volume":"12","author":"Wills","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside.","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ajt.15183","article-title":"Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: a paired kidney analysis.","volume":"19","author":"Leeaphorn","year":"2019","journal-title":"Am J Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00007890-200209270-00014","article-title":"Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection.","volume":"74","author":"McLaughlin","year":"2002","journal-title":"Transplantation"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/jcm9010252","article-title":"Cytomegalovirus viremia after living and deceased donation in kidney transplantation.","volume":"9","author":"Jehn","year":"2020","journal-title":"J Clin Med"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials.","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/1471-2334-13-582","article-title":"Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients.","volume":"13","author":"Johansson","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"85","DOI":"10.15171\/jrip.2016.18","article-title":"The effect of cytomegalovirus infection on acute rejection in kidney transplanted patients.","volume":"5","author":"Hasanzamani","year":"2016","journal-title":"J Renal Inj Prev"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcv.2006.01.015","article-title":"The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.","volume":"36","author":"Reischig","year":"2006","journal-title":"J Clin Virol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients.","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00007890-199304000-00032","article-title":"Cytomegalovirus infection\u2013an etiological factor for rejection? A prospective study in 242 renal transplant patients.","volume":"55","author":"Pouteil-Noble","year":"1993","journal-title":"Transplantation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TRRM.S278655","article-title":"Characteristics and outcomes of cytomegalovirus infection in seropositive kidney transplant recipients in the era of antiviral prophylaxis with valacyclovir: a single-center study in Morocco.","volume":"13","author":"Rezzouk","year":"2021","journal-title":"Transplant Research and Risk Management"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00007890-199803150-00007","article-title":"Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis.","volume":"65","author":"Couchoud","year":"1998","journal-title":"Transplantation"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/lt.20523","article-title":"Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.","volume":"11","author":"Slifkin","year":"2005","journal-title":"Liver Transpl"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial.","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.3390\/v12010021","article-title":"Antiviral agents as therapeutic strategies against cytomegalovirus infections.","volume":"12","author":"Chen","year":"2019","journal-title":"Viruses"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1097\/00007890-199912270-00011","article-title":"Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients.","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00007890-200208270-00026","article-title":"The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation.","volume":"74","author":"Tong","year":"2002","journal-title":"Transplantation"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00007890-200103270-00013","article-title":"Cytomegalovirus infection and graft rejection in renal transplantation.","volume":"71","author":"Dickenmann","year":"2001","journal-title":"Transplantation"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1111\/ajt.15976","article-title":"Cytomegalovirus serologic matching in deceased donor kidney allocation optimizes high- and low-risk (D+R- and D-R-) profiles and does not adversely affect transplant rates.","volume":"20","author":"Lockridge","year":"2020","journal-title":"Am J Transplant"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/00007890-199604270-00022","article-title":"Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: I. Viral induction expression of endothelial cell adhesion molecules: 1.","volume":"61","author":"Steinhoff","year":"1996","journal-title":"Transplantation"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1996.345","article-title":"Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression.","volume":"50","author":"Yilmaz","year":"1996","journal-title":"Kidney Int"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007890-199311000-00011","article-title":"The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts.","volume":"56","author":"Koskinen","year":"1993","journal-title":"Transplantation"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0966-3274(99)80023-9","article-title":"Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms.","volume":"7","author":"Borchers","year":"1999","journal-title":"Transpl Immunol"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fcimb.2020.00283","article-title":"In vivo downregulation of MHC class I molecules by HCMV occurs during all phases of viral replication but is not always complete.","volume":"10","author":"Gabor","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"e01901","DOI":"10.1128\/JVI.01901-19","article-title":"Human cytomegalovirus decreases major histocompatibility complex class II by regulating class II transactivator transcript levels in a myeloid cell line.","volume":"94","author":"Sandhu","year":"2020","journal-title":"J Virol"},{"key":"R58-20250604","first-page":"644","article-title":"Cytomegalovirus induces class II expression in rat heart endothelial cells.","volume":"12","author":"Ustinov","year":"1993","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 1","key":"R59-20250604","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1111\/j.1432-2277.1994.tb01397.x","article-title":"Induction of class II molecules by cytomegalovirus in rat heart endothelial cells is inhibited by ganciclovir.","volume":"7","author":"Ustinov","year":"1994","journal-title":"Transpl Int"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"e153175","DOI":"10.1172\/jci.insight.153175","article-title":"NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.","volume":"6","author":"Pickering","year":"2021","journal-title":"JCI Insight"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"e2116588119","DOI":"10.1073\/pnas.2116588119","article-title":"Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.","volume":"119","author":"Ishiyama","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.exger.2017.04.011","article-title":"Impact of age and cytomegalovirus on CD8+ T-cell compartment remodeling after solid organ transplantation: a one-year follow-up study.","volume":"95","author":"Cantis\u00e1n","year":"2017","journal-title":"Exp Gerontol"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"661551","DOI":"10.3389\/fimmu.2021.661551","article-title":"Association of premature immune aging and cytomegalovirus after solid organ transplant.","volume":"12","author":"Higdon","year":"2021","journal-title":"Front Immunol"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0047-6374(00)00210-4","article-title":"Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study.","volume":"121","author":"Olsson","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/gerona\/60.5.556","article-title":"An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans.","volume":"60","author":"Wikby","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.ajkd.2009.01.271","article-title":"Polyomavirus nephropathy: a current perspective and clinical considerations.","volume":"54","author":"Wiseman","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/nep.12948","article-title":"Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.","volume":"22","author":"Jaw","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/TP.0b013e31816a32fc","article-title":"BK virus nephropathy in renal transplant patients in London.","volume":"85","author":"White","year":"2008","journal-title":"Transplantation"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1038\/s41598-018-23492-2","article-title":"Identification of potential key protein interaction networks of BK virus nephropathy in patients receiving kidney transplantation.","volume":"8","author":"Jia","year":"2018","journal-title":"Sci Rep"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1600-6143.2004.00563.x","article-title":"HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients.","volume":"4","author":"Awadalla","year":"2004","journal-title":"Am J Transplant"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"412902","DOI":"10.1155\/2013\/412902","article-title":"Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection.","volume":"2013","author":"Li","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.xkme.2020.06.015","article-title":"Advances in BK virus complications in organ transplantation and beyond.","volume":"2","author":"Cohen-Bucay","year":"2020","journal-title":"Kidney Med"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/TP.0b013e3181aa8d93","article-title":"Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study.","volume":"88","author":"Manitpisitkul","year":"2009","journal-title":"Transplantation"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction.","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"e13805","DOI":"10.1111\/tid.13805","article-title":"Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimus.","volume":"24","author":"Ge","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3346\/jkms.2008.23.5.814","article-title":"Quantitation of BK virus DNA for diagnosis of BK virus-associated nephropathy in renal transplant recipients.","volume":"23","author":"Sung","year":"2008","journal-title":"J Korean Med Sci"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00007890-199509000-00013","article-title":"Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients.","volume":"60","author":"Hornef","year":"1995","journal-title":"Transplantation"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00007890-200108270-00031","article-title":"Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients.","volume":"72","author":"Babel","year":"2001","journal-title":"Transplantation"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/TP.0000000000001767","article-title":"The immune response to Epstein Barr virus and implications for posttransplant lymphoproliferative disorder.","volume":"101","author":"Martinez","year":"2017","journal-title":"Transplantation"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"e13598","DOI":"10.1111\/tid.13598","article-title":"Successful management of T-cell mediated rejection in a recent kidney transplant recipient with COVID-19 associated severe acute respiratory syndrome.","volume":"23","author":"Mohamed","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12882-022-02713-x","article-title":"Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?","volume":"23","author":"Nouri\u00e9","year":"2022","journal-title":"BMC Nephrol"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.transproceed.2020.10.050","article-title":"Chronic active antibody-mediated rejection following COVID-19 infection in a kidney transplant recipient: a Case Report.","volume":"53","author":"Abuzeineh","year":"2021","journal-title":"Transplant Proc"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40620-021-01192-x","article-title":"Risk of acute rejection in kidney transplant recipients after COVID-19.","volume":"35","author":"V\u00e1squez-Jim\u00e9nez","year":"2022","journal-title":"J Nephrol"},{"key":"R86-20250604","article-title":"Anti-HLA and anti-SARS-CoV2 antibody patterns in kidney transplant recipients with COVID-19.","author":"Girnita","year":"2022","journal-title":"Transplantation"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1097\/TP.0000000000003883","article-title":"Anti-SARS-CoV-2 monoclonal antibodies in solid-organ transplant patients.","volume":"105","author":"Del Bello","year":"2021","journal-title":"Transplantation"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/TP.0000000000003974","article-title":"Monoclonal antibody therapy for SARS-CoV-2 infection in kidney transplant recipients: a case series from Belgium.","volume":"106","author":"Fernandes","year":"2022","journal-title":"Transplantation"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014Final Report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"102396","DOI":"10.1016\/j.dsx.2022.102396","article-title":"An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.","volume":"16","author":"Singh","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients.","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/tri.14029","article-title":"SARS-CoV-2 vaccination in solid-organ transplant recipients: what the clinician needs to know.","volume":"34","author":"Giannella","year":"2021","journal-title":"Transpl Int"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"242ra81","DOI":"10.1126\/scitranslmed.3008793","article-title":"HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans.","volume":"6","author":"Bohne","year":"2014","journal-title":"Sci Transl Med"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ajt.16134","article-title":"On the impact of hepatitis C virus and heterologous immunity on alloimmune responses following liver transplantation.","volume":"21","author":"Merritt","year":"2021","journal-title":"Am J Transplant"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/iid3.386","article-title":"Eradication of hepatitis C virus infection in kidney transplant recipients using direct-acting antiviral therapy: qatar experience.","volume":"9","author":"Alkadi","year":"2021","journal-title":"Immun Inflam Dis"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ndt\/gfr306","article-title":"Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.","volume":"27","author":"Erdbruegger","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/08830185.2013.829469","article-title":"Immunosenescence and immune response in organ transplantation.","volume":"33","author":"Martins","year":"2014","journal-title":"Int Rev Immunol"},{"key":"R98-20250604","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.3389\/fimmu.2019.02549","article-title":"Heterologous cytomegalovirus and allo-reactivity by shared t cell receptor repertoire in kidney transplantation.","volume":"10","author":"Stranavova","year":"2019","journal-title":"Front Immunol"},{"key":"R99-20250604","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.4049\/jimmunol.1500440","article-title":"Cytomegalovirus-induced expression of CD244 after liver transplantation is associated with CD8+ T Cell hyporesponsiveness to alloantigen.","volume":"195","author":"de Mare-Bredemeijer","year":"2015","journal-title":"J Immunol"},{"key":"R100-20250604","first-page":"319","article-title":"Cardiac allograft vasculopathy: a review.","volume":"48","author":"Ramzy","year":"2005","journal-title":"Can J Surg"},{"key":"R101-20250604","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000053961","article-title":"Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model.","volume":"42","author":"Lautenschlager","year":"1999","journal-title":"Intervirology"},{"key":"R102-20250604","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI116622","article-title":"Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.","volume":"92","author":"Lemstr\u00f6m","year":"1993","journal-title":"J Clin Invest"},{"key":"R103-20250604","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/jvi.67.6.3166-3175.1993","article-title":"Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.","volume":"67","author":"S\u00f6derberg","year":"1993","journal-title":"J Virol"},{"key":"R104-20250604","doi-asserted-by":"crossref","first-page":"16255","DOI":"10.1073\/pnas.252630899","article-title":"Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.","volume":"99","author":"Goodrum","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R105-20250604","doi-asserted-by":"crossref","first-page":"eaax9856","DOI":"10.1126\/sciadv.aax9856","article-title":"Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function.","volume":"6","author":"Sen","year":"2020","journal-title":"Sci Adv"},{"key":"R106-20250604","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.4049\/jimmunol.162.8.4806","article-title":"Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression.","volume":"162","author":"Yurochko","year":"1999","journal-title":"J Immunol"},{"key":"R107-20250604","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-6143.2010.03365.x","article-title":"Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV na\u00efve recipients.","volume":"11","author":"Orloff","year":"2011","journal-title":"Am J Transplant"},{"key":"R108-20250604","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/JVI.77.3.2182-2194.2003","article-title":"Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.","volume":"77","author":"Streblow","year":"2003","journal-title":"J Virol"},{"key":"R109-20250604","doi-asserted-by":"crossref","first-page":"e13514","DOI":"10.1111\/tid.13514","article-title":"Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection.","volume":"23","author":"Haese","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R110-20250604","doi-asserted-by":"crossref","first-page":"95659","DOI":"10.1172\/jci.insight.95659","article-title":"Inflammatory macrophage-associated 3-gene signature predicts subclinical allograft injury and graft survival.","volume":"3","author":"Azad","year":"2018","journal-title":"JCI Insight"},{"key":"R111-20250604","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1600-6143.2011.03837.x","article-title":"Is prevention the best treatment? CMV after lung transplantation.","volume":"12","author":"Patel","year":"2012","journal-title":"Am J Transplant"},{"key":"R112-20250604","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.healun.2008.05.009","article-title":"Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.","volume":"27","author":"Valentine","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R113-20250604","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment.","volume":"30","author":"Sawinski","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R114-20250604","first-page":"94","article-title":"Pathogenicity of BK virus on the urinary system.","volume":"73","author":"Krajewski","year":"2020","journal-title":"Cent European J Urol"},{"key":"R115-20250604","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/vim.2015.0099","article-title":"Innate immunity and BK virus: prospective strategies.","volume":"29","author":"Kariminik","year":"2016","journal-title":"Viral Immunol"},{"key":"R116-20250604","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MOT.0b013e3283186b93","article-title":"Cellular immune responses to BK virus.","volume":"13","author":"Comoli","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R117-20250604","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1399-3062.2006.00167.x","article-title":"Polyomavirus-associated nephropathy: update on BK virus-specific immunity.","volume":"8","author":"Comoli","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"R118-20250604","doi-asserted-by":"crossref","first-page":"256923","DOI":"10.1155\/2013\/256923","article-title":"Immunity to polyomavirus BK infection: immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity.","volume":"2013","author":"Comoli","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R119-20250604","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"R120-20250604","doi-asserted-by":"crossref","first-page":"e13927","DOI":"10.1111\/petr.13927","article-title":"Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population: a retrospective analysis of the UNOS\/OPTN database.","volume":"25","author":"Patel","year":"2021","journal-title":"Pediatr Transplant"},{"key":"R121-20250604","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/tid.12530","article-title":"In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.","volume":"18","author":"Mohamed","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"R122-20250604","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-0012.2005.00480.x","article-title":"Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.","volume":"20","author":"Puliyanda","year":"2006","journal-title":"Clin Transplant"},{"key":"R123-20250604","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia.","volume":"5","author":"Bohl","year":"2005","journal-title":"Am J Transplant"},{"key":"R124-20250604","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3748\/wjg.v22.i4.1532","article-title":"Different behaviour of BK-virus infection in liver transplant recipients.","volume":"22","author":"Umbro","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R125-20250604","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ckj\/sfv143","article-title":"BK polyoma virus infection and renal disease in non-renal solid organ transplantation.","volume":"9","author":"Kuppachi","year":"2016","journal-title":"Clin Kidney J"},{"key":"R126-20250604","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/pathogens1020156","article-title":"Epstein-barr virus sequence variation-biology and disease.","volume":"1","author":"Tzellos","year":"2012","journal-title":"Pathogens"},{"key":"R127-20250604","doi-asserted-by":"crossref","first-page":"150835","DOI":"10.1155\/2013\/150835","article-title":"Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?","volume":"2013","author":"Morscio","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R128-20250604","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"R129-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2010.10.016","article-title":"Post-transplant lymphoproliferative disease (PTLD): pharmacological, virological and other determinants.","volume":"63","author":"Stojanova","year":"2011","journal-title":"Pharmacol Res"},{"key":"R130-20250604","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","article-title":"Pathophysiology of COVID-19-associated acute kidney injury.","volume":"17","author":"Legrand","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R131-20250604","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.1890430203","article-title":"High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of healthy individuals detected by nested-PCR.","volume":"43","author":"Cuende","year":"1994","journal-title":"J Med Virol"},{"key":"R132-20250604","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3748\/wjg.15.2561","article-title":"Human herpesvirus 6 infections after liver transplantation.","volume":"15","author":"Abdel Massih","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R133-20250604","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.3390\/v10120730","article-title":"Simultaneous detection of beta and gamma human herpesviruses by multiplex qPCR reveals simple infection and coinfection episodes increasing risk for graft rejection in solid organ transplantation.","volume":"10","author":"S\u00e1nchez-Ponce","year":"2018","journal-title":"Viruses"},{"key":"R134-20250604","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1600-6143.2005.01033.x","article-title":"A surveillance study of adenovirus infection in adult solid organ transplant recipients.","volume":"5","author":"Humar","year":"2005","journal-title":"Am J Transplant"},{"key":"R135-20250604","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1681\/ASN.2010090941","article-title":"Adenovirus interstitial nephritis and rejection in an allograft.","volume":"22","author":"Storsley","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R136-20250604","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/ccr3.1825","article-title":"Not all inflammation in a renal allograft is rejection.","volume":"6","author":"Alquadan","year":"2018","journal-title":"Clin Case Rep"},{"key":"R137-20250604","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.trre.2010.10.003","article-title":"Bacterial infections, alloimmunity, and transplantation tolerance.","volume":"25","author":"Ahmed","year":"2011","journal-title":"Transplant Rev (Orlando)"},{"key":"R138-20250604","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.4049\/jimmunol.180.9.5991","article-title":"Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes.","volume":"180","author":"Wang","year":"2008","journal-title":"J Immunol"},{"key":"R139-20250604","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/j.1600-6143.2006.01489.x","article-title":"TLR engagement prevents transplantation tolerance.","volume":"6","author":"Chen","year":"2006","journal-title":"Am J Transplant"},{"key":"R140-20250604","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/eji.200636249","article-title":"Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection.","volume":"36","author":"McKay","year":"2006","journal-title":"Eur J Immunol"},{"key":"R141-20250604","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200317573","article-title":"Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.","volume":"111","author":"Goldstein","year":"2003","journal-title":"J Clin Invest"},{"key":"R142-20250604","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1399-0012.2005.00436.x","article-title":"Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.","volume":"20","author":"Palmer","year":"2006","journal-title":"Clin Transplant"},{"key":"R143-20250604","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2007.01669.x","article-title":"Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14.","volume":"7","author":"Palmer","year":"2007","journal-title":"Am J Transplant"},{"key":"R144-20250604","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MOT.0000000000000702","article-title":"Impact of the microbiota on solid organ transplant rejection.","volume":"24","author":"Sepulveda","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"R145-20250604","doi-asserted-by":"crossref","first-page":"558644","DOI":"10.3389\/fcimb.2020.558644","article-title":"Does the microbiome affect the outcome of renal transplantation?","volume":"10","author":"Campbell","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R146-20250604","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1615\/CritRevImmunol.v28.i3.40","article-title":"Endothelial injury, alarmins, and allograft rejection.","volume":"28","author":"Rao","year":"2008","journal-title":"Crit Rev Immunol"},{"key":"R147-20250604","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1600-6143.2007.01734.x","article-title":"Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection.","volume":"7","author":"Huang","year":"2007","journal-title":"Am J Transplant"},{"key":"R148-20250604","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/labinvest.2010.141","article-title":"High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response.","volume":"91","author":"Duan","year":"2011","journal-title":"Lab Invest"},{"key":"R149-20250604","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-022-00111-9","article-title":"First pig-to-human heart transplant: what can scientists learn?","volume":"601","author":"Reardon","year":"2022","journal-title":"Nature"},{"key":"R150-20250604","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/ajt.14725","article-title":"Infectious disease risks in xenotransplantation.","volume":"18","author":"Fishman","year":"2018","journal-title":"Am J Transplant"},{"key":"R151-20250604","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.16930","article-title":"First clinical-grade porcine kidney xenotransplant using a human decedent model.","volume":"22","author":"Porrett","year":"2022","journal-title":"Am J Transplant"},{"key":"R152-20250604","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3389\/fimmu.2019.02631","article-title":"Heterologous immunity: role in natural and vaccine-induced resistance to infections.","volume":"10","author":"Agrawal","year":"2019","journal-title":"Front Immunol"},{"key":"R153-20250604","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri820","article-title":"No one is naive: the significance of heterologous T-cell immunity.","volume":"2","author":"Welsh","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R154-20250604","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0167-5699(98)01299-7","article-title":"A very high level of crossreactivity is an essential feature of the T-cell receptor.","volume":"19","author":"Mason","year":"1998","journal-title":"Immunol Today"},{"key":"R155-20250604","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.0902168","article-title":"CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections.","volume":"184","author":"Cornberg","year":"2010","journal-title":"J Immunol"},{"key":"R156-20250604","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1084\/jem.20041337","article-title":"Private specificities of CD8 T cell responses control patterns of heterologous immunity.","volume":"201","author":"Kim","year":"2005","journal-title":"J Exp Med"},{"key":"R157-20250604","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance.","volume":"111","author":"Adams","year":"2003","journal-title":"J Clin Invest"},{"key":"R158-20250604","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1600-6143.2010.03161.x","article-title":"Allografts stimulate cross-reactive virus-specific memory CD8 T cells with private specificity.","volume":"10","author":"Brehm","year":"2010","journal-title":"Am J Transplant"},{"key":"R159-20250604","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1172\/JCI25078","article-title":"Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.","volume":"115","author":"Clute","year":"2005","journal-title":"J Clin Invest"},{"key":"R160-20250604","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/ajt.14279","article-title":"Allo-HLA cross-reactivities of cytomegalovirus-, influenza-, and varicella zoster virus-specific memory T cells are shared by different healthy individuals.","volume":"17","author":"van den Heuvel","year":"2017","journal-title":"Am J Transplant"},{"key":"R161-20250604","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common.","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"R162-20250604","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.3389\/fimmu.2018.02880","article-title":"Cross-reactivity of virus-specific CD8+ T cells against allogeneic HLA-C: possible implications for pregnancy outcome.","volume":"9","author":"van der Zwan","year":"2018","journal-title":"Front Immunol"},{"key":"R163-20250604","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1600-6143.2009.02742.x","article-title":"Contribution of na\u00efve and memory T-cell populations to the human alloimmune response.","volume":"9","author":"Macedo","year":"2009","journal-title":"Am J Transplant"},{"key":"R164-20250604","first-page":"5039","article-title":"Recognition of distinct cross-reactive virus-specific CD8+T cells reveals a unique TCR signature in a clinical setting.","volume":"192","author":"Nguyen","year":"2014","journal-title":"J Immunol Res"},{"key":"R165-20250604","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/ajt.13618","article-title":"Virus-specific CD8(+) T cells cross-reactive to donor-alloantigen are transiently present in the circulation of kidney transplant recipients infected with CMV and\/or EBV.","volume":"16","author":"Heutinck","year":"2016","journal-title":"Am J Transplant"},{"key":"R166-20250604","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4049\/jimmunol.2100404","article-title":"Evolution of cytomegalovirus-responsive T cell clonality following solid organ transplantation.","volume":"207","author":"Higdon","year":"2021","journal-title":"J Immunol"},{"key":"R167-20250604","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/TP.0b013e318208c071","article-title":"Vaccine-induced allo-HLA-reactive memory T cells in a kidney transplantation candidate.","volume":"91","author":"D\u2019Orsogna","year":"2011","journal-title":"Transplantation"},{"key":"R168-20250604","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/TP.0b013e3181ff4ff3","article-title":"Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.","volume":"90","author":"Mifsud","year":"2010","journal-title":"Transplantation"},{"key":"R169-20250604","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/v13122359","article-title":"Heterologous immunity of virus-specific T cells leading to alloreactivity: possible implications for solid organ transplantation.","volume":"13","author":"Karahan","year":"2021","journal-title":"Viruses"},{"key":"R170-20250604","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.4049\/jimmunol.169.10.5387","article-title":"Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28\/CD40 blockade-based regimen.","volume":"169","author":"Williams","year":"2002","journal-title":"J Immunol"},{"key":"R171-20250604","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00251-017-0989-3","article-title":"Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.","volume":"69","author":"D\u2019Orsogna","year":"2017","journal-title":"Immunogenetics"},{"key":"R172-20250604","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1600-6143.2009.02764.x","article-title":"Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"R173-20250604","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1097\/TP.0000000000002369","article-title":"No evidence for cross-reactivity of virus-specific antibodies with HLA alloantigens.","volume":"102","author":"Heidt","year":"2018","journal-title":"Transplantation"},{"key":"R175-20250604","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.173.1.15","article-title":"B cell positive selection: road map to the primary repertoire?","volume":"173","author":"Cancro","year":"2004","journal-title":"J Immunol"},{"key":"R176-20250604","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.4049\/jimmunol.174.11.6639","article-title":"Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2.","volume":"174","author":"Hayashi","year":"2005","journal-title":"J Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:16:39Z","timestamp":1749060999000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":174,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004297","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}